Clinical Trials Logo

Clinical Trial Summary

Platelet function will be tested in individuals on antiplatelet medications to determine the optimal storage methodology.


Clinical Trial Description

Subjects will undergo administration of antiplatelet drugs and then will receive platelets stored in a variety of methods. Platelet function will be measured serially. ;


Study Design


Related Conditions & MeSH terms

  • Platelet Dysfunction Due to Drugs

NCT number NCT03338660
Study type Interventional
Source Northwell Health
Contact
Status Withdrawn
Phase Phase 2
Start date July 15, 2018
Completion date July 15, 2020

See also
  Status Clinical Trial Phase
Completed NCT04206176 - The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease Phase 1/Phase 2
Completed NCT02979158 - Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass N/A
Completed NCT03603249 - Trimetazidine as an Adjunct to Enhance Clopidogrel Response. Phase 2
Completed NCT03111420 - Study of AggreGuide A-100 (ADP) Assay N/A
Recruiting NCT03005704 - Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets N/A
Recruiting NCT06228820 - Aspirin Resistance in Trinidad. Phase 2
Completed NCT04342819 - The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. Phase 2/Phase 3
Completed NCT03121898 - PLATelet Function Operating Room Monitoring
Active, not recruiting NCT03787927 - Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets Phase 1/Phase 2
Withdrawn NCT02974777 - The IDEAL-PCI Extended Registry Phase 4